A failed clinical study has not closed the door on using GLP-1 drugs to treat vascular dementia. Researchers say the science ...

IRVINE, Calif., July 17, 2025 (GLOBE NEWSWIRE) -- MorningStar Laboratories, LLC., (“MSL” or “the Company”), a leading developer of precision diagnostic tests that address unmet clinical needs, is ...

There’s no specific test to confirm you have vascular dementia. Doctors often arrive at a diagnosis after considering your symptoms and observations from a neurological exam, lab tests, and brain ...

IRVINE, Calif., June 25, 2025 (GLOBE NEWSWIRE) -- MorningStar Laboratories, LLC., (“MSL” or “the Company”), is a leading developer of precision diagnostic tests that address unmet clinical needs, is ...

IRVINE, Calif., Aug. 19, 2025 (GLOBE NEWSWIRE) -- MorningStar Laboratories, LLC., ("MSL” or "the Company”), a leading developer of precision diagnostic tests that addresses unmet clinical needs, ...

A new study from Karolinska Institutet, published in Alzheimer’s & Dementia, shows that everyday health problems—like kidney ...

(Ivanhoe Newswire) -- Researchers say it's now possible to simplify blood tests done to detect whether patients have vascular disease. Vascular disease is a group of conditions that affect the ...

Vascular dementia is the second-most common form of dementia after Alzheimer’s. About 2.7 million people in the U.S. are ...

Cold weather amplifies these risks, underscoring the urgent need for earlier recognition, smarter screening, and scalable ...